抗血管內皮生長因子165(VEGF165)單克隆抗體
Anti-Vascular Endothelial Growth Factor 165 (VEGF165) Monoclonal Antibody
用法
Western blotting: 0.2-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Flow cytometry:10μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過一年。避免反復凍融。
贈品
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
APB696Hu61 | 血管內皮生長因子165(VEGF165)活性蛋白 | Cell?culture;?Activity?Assays. |
APB696Hu01 | 血管內皮生長因子165(VEGF165)活性蛋白 | Cell?culture;?Activity?Assays. |
RPB696Hu01 | 血管內皮生長因子165(VEGF165)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPB696Hu61 | 血管內皮生長因子165(VEGF165)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB696Hu01 | 血管內皮生長因子165(VEGF165)多克隆抗體 | WB; IHC; ICC; IP. |
MAB696Hu21 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB; IHC |
MAB696Hu22 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB; IHC |
MAB696Hu25 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB; IHC; ICC; IP. |
MAB696Hu24 | 血管內皮生長因子165(VEGF165)單克隆抗體 | IHC |
MAB696Hu23 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB; IHC; FCM |
MAB696Hu26 | 血管內皮生長因子165(VEGF165)單克隆抗體 | WB |
MAB696Hu27 | 血管內皮生長因子165(VEGF165)單克隆抗體 | IHC |
MAB696Hu29 | 血管內皮生長因子165(VEGF165)單克隆抗體 | IHC |
FAB696Hu08 | 抗血管內皮生長因子165(VEGF165)單克隆抗體 | Flow cytometry. |
FAB696Hu06 | 抗血管內皮生長因子165(VEGF165)單克隆抗體 | Flow cytometry. |
FAB696Hu02 | 抗血管內皮生長因子165(VEGF165)單克隆抗體 | Flow cytometry. |
FAB696Hu04 | 抗血管內皮生長因子165(VEGF165)單克隆抗體 | Flow cytometry. |
SEB696Hu | 血管內皮生長因子165(VEGF165)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB696Hu | 血管內皮生長因子165(VEGF165)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Oncotarget | Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells.[pubmed:29100316] |
Tissue Eng Regen Med | Osteogenic and Angiogenic Potency of VEGF165-Transfected Canine Bone Marrow Mesenchymal Cells Combined with Coral Hydroxyapatite in Vitro[34302695] |